Sarepta Therapeutics, Inc. (SRPT)
USD 120.25
(-4.38%)
USD 120.25
(-4.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -500.99 Million | -325.34 Million | -443.17 Million | 107.46 Million | -456.46 Million | -388.66 Million |
| Net Income | -535.97 Million | -703.48 Million | -418.78 Million | -554.12 Million | -715.07 Million | -361.91 Million |
| Depreciation & Amortization | 58.89 Million | 41.86 Million | 38.01 Million | 26.91 Million | 30.54 Million | 12.24 Million |
| Deferred income taxes | 383.54 Million | - | 15.81 Million | 10.64 Million | -8.44 Million | -1.41 Million |
| Stock-based compensation | 182.51 Million | 233.01 Million | 113.94 Million | 108.07 Million | 78.6 Million | 50.12 Million |
| Change in working capital | -481.08 Million | -39.47 Million | -98.16 Million | 554.05 Million | -66.88 Million | -107.89 Million |
| Other non-cash items | -108.88 Million | 142.73 Million | -93.99 Million | -38.08 Million | 224.78 Million | 20.19 Million |
| Investing Cash Flow | -165.8 Million | -1.04 Billion | 495.41 Million | -121.72 Million | 286.72 Million | -370.48 Million |
| Investments in PPE | -87.34 Million | -30.82 Million | -38.49 Million | -82.2 Million | -62.71 Million | -64.34 Million |
| Acquisitions | - | - | - | - | -172.55 Million | 3.18 Million |
| Investment purchases | -2.04 Billion | -1.93 Billion | -29.98 Million | -1.33 Billion | -1.19 Billion | -1.17 Billion |
| Sales/Maturities of investments | 1.86 Billion | 923.22 Million | 466 Million | 1.18 Billion | 1.71 Billion | 865.81 Million |
| Other Investing Activities | 102 Million | -2.42 Million | 97.89 Million | 104.56 Million | 518.91 Million | -3.18 Million |
| Financing Cash Flow | 125 Million | 232.5 Million | 561.56 Million | 682.32 Million | 642.55 Million | 530.15 Million |
| Debt repayment | -73.75 Million | -823.23 Million | - | -291.11 Million | -244.93 Million | -267.21 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -7.76 Million | -4.79 Million | -4.33 Million | - |
| Common Stock Issuance | 51.24 Million | 30.04 Million | 548.53 Million | 312.05 Million | 365.35 Million | 513.4 Million |
| Other Financing Activities | 147.51 Million | 1.02 Billion | 20.8 Million | 666.17 Million | 526.47 Million | 283.96 Million |
| Accounts receivables | -185.69 Million | -61.63 Million | -51.65 Million | -10.46 Million | -41.83 Million | -19.57 Million |
| Accounts payables | -50.13 Million | 147.57 Million | 23.29 Million | 41.99 Million | 122.97 Million | 90.16 Million |
| Inventory | -147.71 Million | -50.78 Million | -83.77 Million | -60.58 Million | -45.93 Million | -41.84 Million |
| Other working capital | -97.54 Million | -74.62 Million | 13.95 Million | 583.1 Million | -102.09 Million | -136.63 Million |
| Cash at beginning of period | 966.77 Million | 2.12 Billion | 1.51 Billion | 843.64 Million | 370.82 Million | 599.82 Million |
| Cash at end of period | 428.43 Million | 985.8 Million | 2.12 Billion | 1.51 Billion | 843.64 Million | 370.82 Million |
| Capital Expenditure | -87.34 Million | -30.82 Million | -38.49 Million | -82.2 Million | -62.71 Million | -64.34 Million |
| Effect of forex changes on cash | 3.44 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -538.34 Million | -1.13 Billion | 613.81 Million | 668.06 Million | 472.81 Million | -228.99 Million |
| Free Cash Flow | -588.33 Million | -356.17 Million | -481.66 Million | 25.26 Million | -519.17 Million | -453 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.46 Million | 36.11 Million | 45.65 Million | -535.97 Million | -40.93 Million | -23.94 Million |
| Depreciation & Amortization | 12.73 Million | 12.69 Million | 15.23 Million | 58.89 Million | 10.92 Million | 10.79 Million |
| Deferred income taxes | - | - | -11.04 Million | 383.54 Million | 18.72 Million | -7.67 Million |
| Stock-based compensation | 50.48 Million | 40.69 Million | 45.82 Million | 182.51 Million | 48.06 Million | 47.37 Million |
| Change in working capital | -45.37 Million | -329.61 Million | -150.29 Million | -481.08 Million | -154.71 Million | -47.03 Million |
| Other non-cash items | 72.64 Million | 474.14 Million | -36 Thousand | -108.88 Million | 3.23 Million | -101.75 Million |
| Investing Cash Flow | -98.52 Million | 218.79 Million | -64.35 Million | -165.8 Million | -210.57 Million | 96.63 Million |
| Investments in PPE | -29.16 Million | -42.44 Million | -19.03 Million | -87.34 Million | -40.91 Million | -17.9 Million |
| Acquisitions | - | - | 11.23 Million | - | -11.23 Million | - |
| Investment purchases | -330.83 Million | -216.45 Million | -573.53 Million | -2.04 Billion | -645.6 Million | -403.03 Million |
| Sales/Maturities of investments | 261.47 Million | 477.69 Million | 528.21 Million | 1.86 Billion | 475.8 Million | 415.62 Million |
| Other Investing Activities | -69.36 Million | 251.24 Million | -11.23 Million | 102 Million | 11.37 Million | 101.95 Million |
| Financing Cash Flow | 39.91 Million | 22.14 Million | 1.94 Million | 125 Million | 15.4 Million | 5.86 Million |
| Debt repayment | - | - | -129.83 Million | -73.75 Million | - | -28.03 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 39.91 Million | 22.14 Million | 1.94 Million | 51.24 Million | 15.4 Million | 33.89 Million |
| Other Financing Activities | 39.91 Million | 22.14 Million | 129.83 Million | 147.51 Million | 15.4 Million | 5.86 Million |
| Accounts receivables | 18.8 Million | 21.52 Million | -81.47 Million | -185.69 Million | -82.04 Million | -12.97 Million |
| Accounts payables | 77.59 Million | -92.84 Million | 61.08 Million | -50.13 Million | -23.55 Million | 14.88 Million |
| Inventory | -102.46 Million | -60.51 Million | -94.1 Million | -147.71 Million | -26.61 Million | -26.69 Million |
| Other working capital | -39.32 Million | -197.77 Million | -35.8 Million | -97.54 Million | -22.49 Million | -22.25 Million |
| Cash at beginning of period | 427.29 Million | 428.43 Million | 541.93 Million | 966.77 Million | 870.95 Million | 890.69 Million |
| Cash at end of period | 383.62 Million | 427.29 Million | 428.43 Million | 428.43 Million | 561.08 Million | 870.95 Million |
| Capital Expenditure | -29.16 Million | -42.44 Million | -19.03 Million | -87.34 Million | -40.91 Million | -17.9 Million |
| Effect of forex changes on cash | - | - | 3.57 Million | 3.44 Million | - | - |
| Net cash flow / Change in cash | -43.66 Million | -1.14 Million | -113.5 Million | -538.34 Million | -309.87 Million | -19.73 Million |
| Free Cash Flow | -14.22 Million | -284.52 Million | -73.69 Million | -588.33 Million | -155.61 Million | -140.14 Million |
BGS
ARYC
BAKK
6908
GGDVY
002301